Ivonescimab Combined With Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II, Multicenter, Single-Arm Clinical Trial

Press/Media

Period24 Jul 2025

Media coverage

1

Media coverage

  • TitleIvonescimab Combined With Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II, Multicenter, Single-Arm Clinical Trial
    Media name/outletVaccine Daily
    Country/TerritoryUnited States
    Date24/07/25
    PersonsJennifer Yang
View all 1
View less